Article
Noninvasive Prenatal Testing by Nanopore Sequencing of Maternal Plasma DNA: Feasibility Assessment
18 Aug 2015
Abstract excerpt
To the Editor: Noninvasive prenatal testing (NIPT) by maternal plasma DNA sequencing is now clinically available for screening fetal chromosomal aneuploidies; these tests have close to 99% sensitivity and 99% specificity (1). Unlike amniocentesis, maternal peripheral blood sampling does not pose any risk of miscarriage. Consequently, the clinical demand for NIPT has increased substantially since it first became...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
